Starling Oncology, Inc.

DFPH

Exchange: OTC
Industry: Services-Offices & Clinics of Doctors of Medicine
SEC CIK: 0001799191

SEC filings (opens in a new tab)

In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesSTLN STLNW

Superinvestors holding DFPH, Q2 2026

See all superinvestors

No superinvestor reported holding DFPH in Q2 2026.